Request Deal Involvement
Blue Owl Capital led a $150m Series B round in Latigo Biotherapeutics.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Cooley
or
Principals
bidder
BLUE OWL CAPITAL
bidder
ACCESS BIOTECHNOLOGY
target
LATIGO BIOTHERAPEUTICS
bidder
QATAR INVESTMENT AUTHORITY
bidder
SANOFI VENTURES
bidder
DEEP TRACK CAPITAL
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite